![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CCDC87 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ccdc87 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCDC87 mRNA | CTD | PMID:21570461 | CCDC87 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CCDC87 mRNA | CTD | PMID:20064835 | CCDC87 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CCDC87 promoter | CTD | PMID:27901495 | CCDC87 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CCDC87 exon | CTD | PMID:27901495 | CCDC87 | Human | bisphenol A | decreases expression | ISO | Ccdc87 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CCDC87 mRNA | CTD | PMID:25270620 | CCDC87 | Human | bisphenol A | decreases expression | ISO | Ccdc87 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CCDC87 mRNA | CTD | PMID:25181051 | CCDC87 | Human | dimethylarsinic acid | multiple interactions | ISO | Ccdc87 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC87 mRNA | CTD | PMID:34876320 | CCDC87 | Human | ethanol | affects expression | ISO | Ccdc87 (Mus musculus) | 6480464 | Ethanol affects the expression of CCDC87 mRNA | CTD | PMID:30319688 | CCDC87 | Human | furan | increases methylation | ISO | Ccdc87 (Rattus norvegicus) | 6480464 | furan results in increased methylation of CCDC87 gene | CTD | PMID:22079235 | CCDC87 | Human | genistein | decreases expression | ISO | Ccdc87 (Mus musculus) | 6480464 | Genistein results in decreased expression of CCDC87 mRNA | CTD | PMID:32186404 | CCDC87 | Human | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of CCDC87 mRNA | CTD | PMID:35984750 | CCDC87 | Human | methylarsonic acid | multiple interactions | ISO | Ccdc87 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC87 mRNA | CTD | PMID:34876320 | CCDC87 | Human | ozone | multiple interactions | ISO | Ccdc87 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CCDC87 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CCDC87 mRNA | CTD | PMID:34911549 | CCDC87 | Human | sodium arsenate | multiple interactions | ISO | Ccdc87 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC87 mRNA | CTD | PMID:34876320 | CCDC87 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of CCDC87 mRNA | CTD | PMID:34032870 | CCDC87 | Human | sodium arsenite | multiple interactions | ISO | Ccdc87 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC87 mRNA | CTD | PMID:34876320 | CCDC87 | Human | sotorasib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCDC87 mRNA | CTD | PMID:36139627 | CCDC87 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CCDC87 mRNA | CTD | PMID:31533062 | CCDC87 | Human | titanium dioxide | decreases expression | ISO | Ccdc87 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of CCDC87 mRNA | CTD | PMID:35295148 | CCDC87 | Human | trametinib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCDC87 mRNA | CTD | PMID:36139627 | CCDC87 | Human | Tributyltin oxide | decreases expression | ISO | Ccdc87 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of CCDC87 mRNA | CTD | PMID:25270620 | CCDC87 | Human | triptonide | increases expression | ISO | Ccdc87 (Mus musculus) | 6480464 | triptonide results in increased expression of CCDC87 mRNA | CTD | PMID:33045310 | CCDC87 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of CCDC87 mRNA | CTD | PMID:28818685 | CCDC87 | Human | valproic acid | affects expression | ISO | Ccdc87 (Mus musculus) | 6480464 | Valproic Acid affects the expression of CCDC87 mRNA | CTD | PMID:17292431 | |